SCHEMBL12818698

SCHEMBL12818698

Cc1nc2cc(S(=O)(=O)N3CCOc4ccc(-c5ncc(C#N)s5)cc43)ccc2o1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 2/20 0.37
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ CPT1A P50416 3/20 0.37
▸ CPT1B Q92523 3/20 0.37
▸ GCK P35557 1/20 0.36
▸ MAPT P10636 3/20 0.34
▸ TP53 P04637 1/20 0.34
▸ PDE3B Q13370 4/20 0.34
▸ PDE3A Q14432 4/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ HRH3 Q9Y5N1 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12817667 0.87 PGR (0.39) CYP2C9MEN1KMT2ACPT1ACPT1B
SCHEMBL12817711 0.85 GCK (0.36) MEN1KMT2ACPT1ACPT1BGCK
SCHEMBL1817591 0.85 CYP2C9 (0.51) CYP2C9MEN1KMT2ACPT1ACPT1B
SCHEMBL12817769 0.85 CYP2C9 (0.38) CYP2C9MEN1KMT2ACPT1ACPT1B
SCHEMBL12819198 0.85 LMNA (0.41) CYP2C9MEN1KMT2ACPT1ACPT1B
SCHEMBL12818652 0.83 MEN1 (0.40) CYP2C9MEN1KMT2ACPT1ACPT1B
SCHEMBL12818994 0.81 PGR (0.39) CYP2C9MEN1KMT2ACPT1ACPT1B
SCHEMBL12818456 0.81 KDM2B (0.37) CYP2C9MEN1KMT2ACPT1ACPT1B
SCHEMBL12818134 0.81 CYP2C9 (0.40) CYP2C9MEN1KMT2ACPT1ACPT1B
SCHEMBL12818990 0.80 CYP2C9 (0.38) CYP2C9MEN1KMT2ACPT1ACPT1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO claimed
WO-2012130306-A1 BICYCLIC 2,3-DIHYRDOBENZAZINE COMPOUNDS FOR USE IN THERAPY ELARA PHARMACEUTICALS GMBH (DE) 2012-10-04 — — WO disclosed
Send feedback